Daniel Hanbury, manager of the chart-topping £630m River & Mercantile UK Equity Smaller Companies fund, discusses valuations, hidden gems and whether the UK stock market can finally deliver a bout of outperformance this year.

Alex Chartres, manager of the £4bn Ruffer Total Return fund, discusses the protective qualities of UK equities, that famous bitcoin buy, conventional bonds as ‘killing fields’, and markets caught napping as a new inflationary era dawns.

John Chatfeild-Roberts, the fund-picking heavyweight who heads up Jupiter’s £6.5bn Merlin range, discusses why he still believes in Terry Smith, personal lessons from Neil Woodford’s downfall, getting the rise of passive investing wrong and the key traits he hunts for in active managers.

Anthony Cross and Julian Fosh, managers of the top-performing and now giant £6bn Liontrust Special Situations fund, discuss the nature of competitive advantage among UK stocks, backing Shell and BP during the energy crisis, and why smaller companies remain the kings of compounding.

Jeremy Podger, manager of the £3.3bn Fidelity Global Special Situations fund, discusses breaking up big tech, controversial takeovers and why he’s getting ready for ‘another leg’ of the value rally.

Dan Carter, manager of the Jupiter Japan Income fund, discusses investing for both income and growth in the country’s inefficient stock market, getting ‘creative’ as tech valuations rise, an unusual Olympics and why depressed Japanese equities are due a bounce.

Sue Noffke, head of UK equities at Schroders, discusses dividends, the UK stock market recovery and her battle to make businesses like oil giant Royal Dutch Shell sustainable.

Veteran Premier Miton fund manager Gervais Williams talks to Jeremy Gordon about how his funds and investment trusts bounced back last year after a shocking 2019, the joys of the Alternative Investment Market and why the outlook has never been better for the UK’s smallest listed companies.

Keith Ashworth-Lord, manager of Sanford DeLand’s top-performing UK Buffettology Fund, talks to Jeremy Gordon about his investment philosophy inspired by the ‘Oracle of Omaha’, why he’s not worried about the recent ‘value’ rotation and the importance of not taking profits.

(Sponsored) Gavin Lumsden talks to BB Healthcare fund manager Paul Major, life sciences leader Dr Annalisa Jenkins, and cancer expert Professor Justin Stebbing about the challenges we face keeping coronavirus at bay.